Allergan sues Valeant, Ackman for alleged insider trading

vendredi 1 août 2014

Ackman, founder and CEO of hedge fund Pershing Square Capital Management, speaks at the Sohn Investment Conference in New York Allergan Inc , which is fighting a $51 billion hostile takeover bid from Valeant Pharmaceuticals International and activist investor William Ackman, on Friday filed a federal lawsuit alleging they violated ...








via Business News http://ift.tt/1rWDszY

0 commentaires:

Enregistrer un commentaire